Suven Life to raise funds for trial of Alzhemimer, stk up
April 8th, 2009
Suven Life Sciences had touched an intraday high of Rs 13.69 and an intraday low of Rs 12.40. At 12:18 pm, the share was quoting at Rs 13.60, up Rs 0.91, or 7.17%.
The company is going to raise funds for phase II trial of Alzhemimer molecule, reports The Economic Times.
It was trading with volumes of 41,558 shares. On Monday the share closed up 1.60% or Rs 0.20 at Rs 12.69.